Stock Events

Stock Events

Aptevo Therapeutics (APVO) Q2 2026 Earnings

13MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-87.8

-60.4

-33

-5.6

Details

Expected EPS

-5.6

Actual EPS

-6.41

Surprise EPS

-0.81

Surprise Percent

+14.46%

Description

Aptevo Therapeutics (APVO) has reported earnings of -6.41 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.